Stock 6669 ACOTEC SCIENTIFIC HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Acotec Scientific Holdings Limited

Equities

6669

KYG0096M1096

Market Closed - Hong Kong S.E.
Other stock markets
 04:09:05 2024-06-07 am EDT 		5-day change 1st Jan Change
7.55 HKD +0.53% Intraday chart for Acotec Scientific Holdings Limited +0.67% -33.07%
Mar. 27 Acotec Scientific Gets Registration Approval for Micro-Catheter from Chinese Regulator MT
Mar. 26 Acotec Scientific Holdings Limited Announces Approval for Vericor-RS by PRC National Medical Products Administration CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The company returns high margins, thereby supporting business profitability.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • With a 2024 P/E ratio at 26.96 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
ACOTEC SCIENTIFIC HOLDINGS LIMITED Stock Acotec Scientific Holdings Limited
-33.07% 303M -
PENUMBRA, INC. Stock Penumbra, Inc.
-24.88% 7.32B
C+
MASIMO CORPORATION Stock Masimo Corporation
+7.04% 6.66B
C-
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+15.10% 5.5B
D+
GETINGE AB Stock Getinge AB
-17.39% 4.88B
B
APT MEDICAL INC. Stock APT Medical Inc.
+14.96% 4.1B -
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-20.83% 3.89B
B-
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-25.03% 2.83B
C
NOVOCURE LIMITED Stock NovoCure Limited
+44.01% 2.31B
C-
SKAN GROUP AG Stock SKAN Group AG
+1.86% 2.07B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 6669 Stock
  4. Ratings Acotec Scientific Holdings Limited